Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Other financing activities (2021 - 2025)

Historic Other financing activities for Definitive Healthcare (DH) over the last 5 years, with Q3 2025 value amounting to $1.1 million.

  • Definitive Healthcare's Other financing activities rose 11474.75% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 million, marking a year-over-year decrease of 495.2%. This contributed to the annual value of $7.5 million for FY2024, which is 7030.69% up from last year.
  • According to the latest figures from Q3 2025, Definitive Healthcare's Other financing activities is $1.1 million, which was up 11474.75% from $609000.0 recorded in Q2 2025.
  • In the past 5 years, Definitive Healthcare's Other financing activities registered a high of $7.5 million during Q4 2024, and its lowest value of $126000.0 during Q1 2021.
  • Its 5-year average for Other financing activities is $2.5 million, with a median of $1.4 million in 2022.
  • As far as peak fluctuations go, Definitive Healthcare's Other financing activities soared by 93095.24% in 2022, and later plummeted by 7151.18% in 2023.
  • Quarter analysis of 5 years shows Definitive Healthcare's Other financing activities stood at $5.8 million in 2021, then tumbled by 51.4% to $2.8 million in 2022, then soared by 56.27% to $4.4 million in 2023, then skyrocketed by 71.47% to $7.5 million in 2024, then tumbled by 85.92% to $1.1 million in 2025.
  • Its Other financing activities was $1.1 million in Q3 2025, compared to $609000.0 in Q2 2025 and $1.9 million in Q1 2025.